Demant A/S (OTCMKTS:WILYY – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
Profitability
This table compares Demant A/S and Envoy Medical’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Demant A/S | N/A | N/A | N/A |
Envoy Medical | N/A | N/A | -112.11% |
Analyst Recommendations
This is a breakdown of current ratings and target prices for Demant A/S and Envoy Medical, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Demant A/S | 0 | 0 | 2 | 0 | 3.00 |
Envoy Medical | 0 | 0 | 3 | 0 | 3.00 |
Institutional & Insider Ownership
8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Demant A/S and Envoy Medical’s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Demant A/S | $3.26 billion | 2.39 | $260.63 million | N/A | N/A |
Envoy Medical | $297,000.00 | 143.21 | -$29.91 million | N/A | N/A |
Demant A/S has higher revenue and earnings than Envoy Medical.
Risk and Volatility
Demant A/S has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500.
Summary
Envoy Medical beats Demant A/S on 6 of the 9 factors compared between the two stocks.
About Demant A/S
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.